Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Network neuroscience of apathy in cerebrovascular disease.

Tay J, Lisiecka-Ford DM, Hollocks MJ, Tuladhar AM, Barrick TR, Forster A, O'Sullivan MJ, Husain M, de Leeuw FE, Morris RG, Markus HS.

Prog Neurobiol. 2020 Mar 6:101785. doi: 10.1016/j.pneurobio.2020.101785. [Epub ahead of print] Review.

PMID:
32151533
2.

Simple MRI score aids prediction of dementia in cerebral small vessel disease.

Amin Al Olama A, Wason JMS, Tuladhar AM, van Leijsen EMC, Koini M, Hofer E, Morris RG, Schmidt R, de Leeuw FE, Markus HS.

Neurology. 2020 Mar 24;94(12):e1294-e1302. doi: 10.1212/WNL.0000000000009141. Epub 2020 Mar 2.

PMID:
32123050
3.

Alterations and test-retest reliability of functional connectivity network measures in cerebral small vessel disease.

Gesierich B, Tuladhar AM, Ter Telgte A, Wiegertjes K, Konieczny MJ, Finsterwalder S, Hübner M, Pirpamer L, Koini M, Abdulkadir A, Franzmeier N, Norris DG, Marques JP, Zu Eulenburg P, Ewers M, Schmidt R, de Leeuw FE, Duering M.

Hum Brain Mapp. 2020 Feb 22. doi: 10.1002/hbm.24967. [Epub ahead of print]

4.

Temporal Dynamics of Cortical Microinfarcts in Cerebral Small Vessel Disease.

Ter Telgte A, Wiegertjes K, Gesierich B, Baskaran BS, Marques JP, Kuijf HJ, Norris DG, Tuladhar AM, Duering M, de Leeuw FE.

JAMA Neurol. 2020 Feb 17. doi: 10.1001/jamaneurol.2019.5106. [Epub ahead of print]

PMID:
32065609
5.

Ischaemic stroke in young adults: a global perspective.

Boot E, Ekker MS, Putaala J, Kittner S, De Leeuw FE, Tuladhar AM.

J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):411-417. doi: 10.1136/jnnp-2019-322424. Epub 2020 Feb 3. Review.

PMID:
32015089
6.

Injectable hydrogel enables local and sustained co-delivery to the brain: Two clinically approved biomolecules, cyclosporine and erythropoietin, accelerate functional recovery in rat model of stroke.

Tuladhar A, Obermeyer JM, Payne SL, Siu RCW, Zand S, Morshead CM, Shoichet MS.

Biomaterials. 2020 Mar;235:119794. doi: 10.1016/j.biomaterials.2020.119794. Epub 2020 Jan 16.

PMID:
31981761
7.

Synthesis and surface spectroscopy of α-pinene isotopologues and their corresponding secondary organic material.

Upshur MA, Vega MM, Bé AG, Chase HM, Zhang Y, Tuladhar A, Chase ZA, Fu L, Ebben CJ, Wang Z, Martin ST, Geiger FM, Thomson RJ.

Chem Sci. 2019 Jul 31;10(36):8390-8398. doi: 10.1039/c9sc02399b. eCollection 2019 Sep 28.

8.

Organothiol Monolayer Formation Directly on Muscovite Mica.

de Poel W, Brugman SJT, van de Ven KHA, Gasseling A, de Lange J, Townsend ER, Engwerda AHJ, Jankowski M, Blijlevens MAR, Werkhoven BL, Drnec J, Carlà F, Felici R, Tuladhar A, Adhikari NM, De Yoreo JJ, Elemans JAAW, van Enckevort WJP, Rowan AE, Vlieg E.

Angew Chem Int Ed Engl. 2020 Feb 3;59(6):2323-2327. doi: 10.1002/anie.201913327. Epub 2019 Dec 18.

9.

Structural network changes in cerebral small vessel disease.

Tuladhar AM, Tay J, van Leijsen E, Lawrence AJ, van Uden IWM, Bergkamp M, van der Holst E, Kessels RPC, Norris D, Markus HS, De Leeuw FE.

J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):196-203. doi: 10.1136/jnnp-2019-321767. Epub 2019 Nov 19.

PMID:
31744851
10.

Global Outcome Assessment Life-long after stroke in young adults initiative-the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysis.

Ekker MS, Jacob MA, van Dongen MM, Aarnio K, Annamalai AK, Arauz A, Arnold M, Barboza MA, Bolognese M, Brouns R, Chuluun B, Chuluunbaatar E, Dagvajantsan B, Debette S, Don A, Enzinger C, Ekizoglu E, Fandler-Höfler S, Fazekas F, Fromm A, Gattringer T, Gulli G, Hoffmann M, Hora TF, Jern C, Jood K, Kamouchi M, Kim YS, Kitazono T, Kittner SJ, Kleinig TJ, Klijn CJM, Korv J, Lee TH, Leys D, Maaijwee NA, Martinez-Majander N, Marto JP, Mehndiratta MM, Mifsud V, Montanaro VV, Owolabi MO, Patel VB, Phillips MC, Piechowski-Iozwiak B, Pikula A, Ruiz-Sandoval JL, Sarnowski B, Schreuder FH, Swartz RH, Tan KS, Tanne D, Tatlisumak T, Thijs V, Tuladhar AM, Viana-Baptista M, Vibo R, Wu TY, Yesilot N, Waje-Andreassen U, Pezzini A, Putaala J, de Leeuw FE.

BMJ Open. 2019 Nov 14;9(11):e031144. doi: 10.1136/bmjopen-2019-031144.

11.

Longitudinal changes in rich club organization and cognition in cerebral small vessel disease.

van Leijsen EMC, van Uden IWM, Bergkamp MI, van der Holst HM, Norris DG, Claassen JAHR, Kessels RPC, de Leeuw FE, Tuladhar AM.

Neuroimage Clin. 2019;24:102048. doi: 10.1016/j.nicl.2019.102048. Epub 2019 Oct 22.

12.

Cooperative Adsorption of Trehalose to DPPC Monolayers at the Water-Air Interface Studied with Vibrational Sum Frequency Generation.

Link KA, Spurzem GN, Tuladhar A, Chase Z, Wang Z, Wang H, Walker RA.

J Phys Chem B. 2019 Oct 24;123(42):8931-8938. doi: 10.1021/acs.jpcb.9b07770. Epub 2019 Oct 11.

PMID:
31553603
13.

The role of small diffusion-weighted imaging lesions in cerebral small vessel disease.

Wiegertjes K, Ter Telgte A, Oliveira PB, van Leijsen EMC, Bergkamp MI, van Uden IWM, Ghafoorian M, van der Holst HM, Norris DG, Platel B, Klijn CJM, Tuladhar AM, de Leeuw FE.

Neurology. 2019 Oct 22;93(17):e1627-e1634. doi: 10.1212/WNL.0000000000008364. Epub 2019 Sep 17.

PMID:
31530710
14.

Hydrogen bonding and molecular orientations across thin water films on sapphire.

Boily JF, Fu L, Tuladhar A, Lu Z, Legg BA, Wang ZM, Wang H.

J Colloid Interface Sci. 2019 Nov 1;555:810-817. doi: 10.1016/j.jcis.2019.08.028. Epub 2019 Aug 9.

PMID:
31425917
15.

Contribution of acute infarcts to cerebral small vessel disease progression.

Ter Telgte A, Wiegertjes K, Gesierich B, Marques JP, Huebner M, de Klerk JJ, Schreuder FHBM, Araque Caballero MA, Kuijf HJ, Norris DG, Klijn CJM, Dichgans M, Tuladhar AM, Duering M, de Leeuw FE.

Ann Neurol. 2019 Oct;86(4):582-592. doi: 10.1002/ana.25556. Epub 2019 Aug 12. Erratum in: Ann Neurol. 2019 Nov;86(5):807.

16.

Organic Enrichment at Aqueous Interfaces: Cooperative Adsorption of Glucuronic Acid to DPPC Monolayers Studied with Vibrational Sum Frequency Generation.

Link KA, Spurzem GN, Tuladhar A, Chase Z, Wang Z, Wang H, Walker RA.

J Phys Chem A. 2019 Jul 5;123(26):5621-5632. doi: 10.1021/acs.jpca.9b02255. Epub 2019 Jun 24.

PMID:
31244118
17.

Investigating the origin and evolution of cerebral small vessel disease: The RUN DMC - InTENse study.

Ter Telgte A, Wiegertjes K, Tuladhar AM, Noz MP, Marques JP, Gesierich B, Huebner M, Mutsaerts HM, Elias-Smale SE, Beelen MJ, Ropele S, Kessels RP, Riksen NP, Klijn CJ, Norris DG, Duering M, de Leeuw FE.

Eur Stroke J. 2018 Dec;3(4):369-378. doi: 10.1177/2396987318776088. Epub 2018 May 9.

18.

Cognitive consequences of regression of cerebral small vessel disease.

van Leijsen EM, Bergkamp MI, van Uden IW, Cooijmans S, Ghafoorian M, van der Holst HM, Norris DG, Kessels RP, Platel B, Tuladhar AM, de Leeuw FE.

Eur Stroke J. 2019 Mar;4(1):85-89. doi: 10.1177/2396987318820790. Epub 2018 Dec 21.

19.

Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.

Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, Li L, Lovelock C, Chabriat H, Hennerici M, Wong YK, Mak HKF, Prats-Sánchez L, Martínez-Domeño A, Inamura S, Yoshifuji K, Arsava EM, Horstmann S, Purrucker J, Lam BYK, Wong A, Kim YD, Song TJ, Schrooten M, Lemmens R, Eppinger S, Gattringer T, Uysal E, Tanriverdi Z, Bornstein NM, Assayag EB, Hallevi H, Tanaka J, Hara H, Coutts SB, Hert L, Polymeris A, Seiffge DJ, Lyrer P, Algra A, Kappelle J, Al-Shahi Salman R, Jäger HR, Lip GYH, Mattle HP, Panos LD, Mas JL, Legrand L, Karayiannis C, Phan T, Gunkel S, Christ N, Abrigo J, Leung T, Chu W, Chappell F, Makin S, Hayden D, Williams DJ, Kooi ME, van Dam-Nolen DHK, Barbato C, Browning S, Wiegertjes K, Tuladhar AM, Maaijwee N, Guevarra C, Yatawara C, Mendyk AM, Delmaire C, Köhler S, van Oostenbrugge R, Zhou Y, Xu C, Hilal S, Gyanwali B, Chen C, Lou M, Staals J, Bordet R, Kandiah N, de Leeuw FE, Simister R, van der Lugt A, Kelly PJ, Wardlaw JM, Soo Y, Fluri F, Srikanth V, Calvet D, Jung S, Kwa VIH, Engelter ST, Peters N, Smith EE, Yakushiji Y, Orken DN, Fazekas F, Thijs V, Heo JH, Mok V, Veltkamp R, Ay H, Imaizumi T, Gomez-Anson B, Lau KK, Jouvent E, Rothwell PM, Toyoda K, Bae HJ, Marti-Fabregas J, Werring DJ; Microbleeds International Collaborative Network.

Lancet Neurol. 2019 Jul;18(7):653-665. doi: 10.1016/S1474-4422(19)30197-8. Epub 2019 May 23. Erratum in: Lancet Neurol. 2019 Sep;18(9):e8. Lancet Neurol. 2020 Feb;19(2):e2.

20.

Thalamus: a key player in alcohol use disorder and Korsakoff's syndrome.

Tuladhar AM, de Leeuw FE.

Brain. 2019 May 1;142(5):1170-1172. doi: 10.1093/brain/awz096. No abstract available.

21.

Apathy is associated with large-scale white matter network disruption in small vessel disease.

Tay J, Tuladhar AM, Hollocks MJ, Brookes RL, Tozer DJ, Barrick TR, Husain M, de Leeuw FE, Markus HS.

Neurology. 2019 Mar 12;92(11):e1157-e1167. doi: 10.1212/WNL.0000000000007095. Epub 2019 Feb 8.

22.

Direct Observation of the Orientational Anisotropy of Buried Hydroxyl Groups inside Muscovite Mica.

Tuladhar A, Chase ZA, Baer MD, Legg BA, Tao J, Zhang S, Winkelman AD, Wang Z, Mundy CJ, De Yoreo JJ, Wang HF.

J Am Chem Soc. 2019 Feb 6;141(5):2135-2142. doi: 10.1021/jacs.8b12483. Epub 2019 Jan 24.

PMID:
30615440
23.

Local Delivery of Brain-Derived Neurotrophic Factor Enables Behavioral Recovery and Tissue Repair in Stroke-Injured Rats.

Obermeyer JM, Tuladhar A, Payne SL, Ho E, Morshead CM, Shoichet MS.

Tissue Eng Part A. 2019 Aug;25(15-16):1175-1187. doi: 10.1089/ten.TEA.2018.0215. Epub 2019 Feb 27.

PMID:
30612516
24.

Structural white matter networks in myotonic dystrophy type 1.

van Dorst M, Okkersen K, Kessels RPC, Meijer FJA, Monckton DG, van Engelen BGM, Tuladhar AM, Raaphorst J; OPTIMISTIC consortium.

Neuroimage Clin. 2019;21:101615. doi: 10.1016/j.nicl.2018.101615. Epub 2018 Nov 28.

25.

Effectors of thioredoxin reductase: Brevetoxins and manumycin-A.

Tuladhar A, Hondal RJ, Colon R, Hernandez EL, Rein KS.

Comp Biochem Physiol C Toxicol Pharmacol. 2019 Mar;217:76-86. doi: 10.1016/j.cbpc.2018.11.015. Epub 2018 Nov 23.

PMID:
30476593
26.

Initial cell maturity changes following transplantation in a hyaluronan-based hydrogel and impacts therapeutic success in the stroke-injured rodent brain.

Payne SL, Tuladhar A, Obermeyer JM, Varga BV, Teal CJ, Morshead CM, Nagy A, Shoichet MS.

Biomaterials. 2019 Feb;192:309-322. doi: 10.1016/j.biomaterials.2018.11.020. Epub 2018 Nov 15.

PMID:
30468998
27.

Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.

Bergkamp MI, Tuladhar AM, van der Holst HM, van Leijsen EMC, Ghafoorian M, van Uden IWM, van Dijk EJ, Norris DG, Platel B, Esselink RAJ, Leeuw FE.

Parkinsonism Relat Disord. 2019 Apr;61:94-100. doi: 10.1016/j.parkreldis.2018.11.010. Epub 2018 Nov 8.

PMID:
30448096
28.

Periodontal Health Status and Pregnancy Outcomes: A Survey in Medical Doctors.

Gupta S, Shrestha B, Gupta N, Tuladhar A, Kc S, Dhami B.

JNMA J Nepal Med Assoc. 2018 Mar-Apr;56(210):565-571.

PMID:
30375998
29.

Risk of Nursing Home Admission in Cerebral Small Vessel Disease.

Bergkamp MI, Wissink JGJ, van Leijsen EMC, Ghafoorian M, Norris DG, van Dijk EJ, Platel B, Tuladhar AM, de Leeuw FE.

Stroke. 2018 Nov;49(11):2659-2665. doi: 10.1161/STROKEAHA.118.021993.

PMID:
30355195
30.

Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.

van Leijsen EMC, Tay J, van Uden IWM, Kooijmans ECM, Bergkamp MI, van der Holst HM, Ghafoorian M, Platel B, Norris DG, Kessels RPC, Markus HS, Tuladhar AM, de Leeuw FE.

Hippocampus. 2019 Jun;29(6):500-510. doi: 10.1002/hipo.23039. Epub 2018 Nov 23.

PMID:
30307080
31.

[Headache: consider cavernous sinus thrombophlebitis].

Deliran SS, Sondag L, Leijten QH, Tuladhar AM, Meijer FJA.

Ned Tijdschr Geneeskd. 2018 Aug 16;162. pii: D2907. Dutch.

PMID:
30212024
32.

Ultrabroadband mid-infrared noncollinear difference frequency generation in a silver thiogallate crystal.

Aulin YV, Tuladhar A, Borguet E.

Opt Lett. 2018 Sep 15;43(18):4402-4405. doi: 10.1364/OL.43.004402.

PMID:
30211875
33.

Epidemiology, aetiology, and management of ischaemic stroke in young adults.

Ekker MS, Boot EM, Singhal AB, Tan KS, Debette S, Tuladhar AM, de Leeuw FE.

Lancet Neurol. 2018 Sep;17(9):790-801. doi: 10.1016/S1474-4422(18)30233-3. Review.

PMID:
30129475
34.

Biomaterials driving repair after stroke.

Tuladhar A, Shoichet MS.

Nat Mater. 2018 Jul;17(7):573-574. doi: 10.1038/s41563-018-0124-3. No abstract available.

PMID:
29941949
35.

Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden.

Duering M, Konieczny MJ, Tiedt S, Baykara E, Tuladhar AM, Leijsen EV, Lyrer P, Engelter ST, Gesierich B, Achmüller M, Barro C, Adam R, Ewers M, Dichgans M, Kuhle J, de Leeuw FE, Peters N.

J Stroke. 2018 May;20(2):228-238. doi: 10.5853/jos.2017.02565. Epub 2018 May 31.

36.

Cerebral small vessel disease: from a focal to a global perspective.

Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw FE.

Nat Rev Neurol. 2018 Jul;14(7):387-398. doi: 10.1038/s41582-018-0014-y. Review.

PMID:
29802354
37.

Progression of White Matter Hyperintensities Preceded by Heterogeneous Decline of Microstructural Integrity.

van Leijsen EMC, Bergkamp MI, van Uden IWM, Ghafoorian M, van der Holst HM, Norris DG, Platel B, Tuladhar AM, de Leeuw FE.

Stroke. 2018 Jun;49(6):1386-1393. doi: 10.1161/STROKEAHA.118.020980. Epub 2018 May 3.

PMID:
29724890
38.

Manumycin A Is a Potent Inhibitor of Mammalian Thioredoxin Reductase-1 (TrxR-1).

Tuladhar A, Rein KS.

ACS Med Chem Lett. 2018 Mar 5;9(4):318-322. doi: 10.1021/acsmedchemlett.7b00489. eCollection 2018 Apr 12.

39.

Free water determines diffusion alterations and clinical status in cerebral small vessel disease.

Duering M, Finsterwalder S, Baykara E, Tuladhar AM, Gesierich B, Konieczny MJ, Malik R, Franzmeier N, Ewers M, Jouvent E, Biessels GJ, Schmidt R, de Leeuw FE, Pasternak O, Dichgans M.

Alzheimers Dement. 2018 Jun;14(6):764-774. doi: 10.1016/j.jalz.2017.12.007. Epub 2018 Feb 16.

40.

White matter changes and gait decline in cerebral small vessel disease.

van der Holst HM, Tuladhar AM, Zerbi V, van Uden IWM, de Laat KF, van Leijsen EMC, Ghafoorian M, Platel B, Bergkamp MI, van Norden AGW, Norris DG, van Dijk EJ, Kiliaan AJ, de Leeuw FE.

Neuroimage Clin. 2017 Dec 7;17:731-738. doi: 10.1016/j.nicl.2017.12.007. eCollection 2018.

41.

Pregnancy and ischemic stroke: a practical guide to management.

van Alebeek ME, de Heus R, Tuladhar AM, de Leeuw FE.

Curr Opin Neurol. 2018 Feb;31(1):44-51. doi: 10.1097/WCO.0000000000000522. Review.

PMID:
29120921
42.

Nonlinear temporal dynamics of cerebral small vessel disease: The RUN DMC study.

van Leijsen EMC, van Uden IWM, Ghafoorian M, Bergkamp MI, Lohner V, Kooijmans ECM, van der Holst HM, Tuladhar AM, Norris DG, van Dijk EJ, Rutten-Jacobs LCA, Platel B, Klijn CJM, de Leeuw FE.

Neurology. 2017 Oct 10;89(15):1569-1577. doi: 10.1212/WNL.0000000000004490. Epub 2017 Sep 6.

43.

Brain imaging in myotonic dystrophy type 1: A systematic review.

Okkersen K, Monckton DG, Le N, Tuladhar AM, Raaphorst J, van Engelen BGM.

Neurology. 2017 Aug 29;89(9):960-969. doi: 10.1212/WNL.0000000000004300. Epub 2017 Aug 2. Review.

PMID:
28768849
44.

Disease progression and regression in sporadic small vessel disease-insights from neuroimaging.

van Leijsen EMC, de Leeuw FE, Tuladhar AM.

Clin Sci (Lond). 2017 Jun 1;131(12):1191-1206. doi: 10.1042/CS20160384. Review.

PMID:
28566448
45.

Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1.

Chen W, Tuladhar A, Rolle S, Lai Y, Rodriguez Del Rey F, Zavala CE, Liu Y, Rein KS.

Toxicol Appl Pharmacol. 2017 Aug 15;329:58-66. doi: 10.1016/j.taap.2017.05.027. Epub 2017 May 25.

46.

Increased Risk of Cerebrovascular Events in Young Cancer Survivors: The Downside of Surviving Cancer.

Tuladhar AM, de Leeuw FE.

Circulation. 2017 Mar 28;135(13):1211-1213. doi: 10.1161/CIRCULATIONAHA.117.027329. No abstract available.

PMID:
28348090
47.

Disruption of rich club organisation in cerebral small vessel disease.

Tuladhar AM, Lawrence A, Norris DG, Barrick TR, Markus HS, de Leeuw FE.

Hum Brain Mapp. 2017 Apr;38(4):1751-1766. doi: 10.1002/hbm.23479. Epub 2016 Dec 9.

PMID:
27935154
48.

Baseline Cerebral Small Vessel Disease Is Not Associated with Gait Decline After Five Years.

van der Holst HM, van Uden IWM, de Laat KF, van Leijsen EMC, van Norden AGW, Norris DG, van Dijk EJ, Tuladhar AM, de Leeuw FE.

Mov Disord Clin Pract. 2016 Nov 16;4(3):374-382. doi: 10.1002/mdc3.12435. eCollection 2017 May-Jun.

49.

Remote Lower White Matter Integrity Increases the Risk of Long-Term Cognitive Impairment After Ischemic Stroke in Young Adults.

Schaapsmeerders P, Tuladhar AM, Arntz RM, Franssen S, Maaijwee NA, Rutten-Jacobs LC, Schoonderwaldt HC, Dorresteijn LD, van Dijk EJ, Kessels RP, de Leeuw FE.

Stroke. 2016 Oct;47(10):2517-25. doi: 10.1161/STROKEAHA.116.014356. Epub 2016 Sep 13.

PMID:
27625378
50.

Late-onset depressive symptoms increase the risk of dementia in small vessel disease.

van Uden IW, van der Holst HM, van Leijsen EM, Tuladhar AM, van Norden AG, de Laat KF, Claassen JA, van Dijk EJ, Kessels RP, Richard E, Tendolkar I, de Leeuw FE.

Neurology. 2016 Sep 13;87(11):1102-9. doi: 10.1212/WNL.0000000000003089. Epub 2016 Aug 12.

PMID:
27521430

Supplemental Content

Loading ...
Support Center